Radiology

Former Founding Director of the NIH Center for Interventional Oncology & Chief of Interventional Radiology, Dr. Bradford Wood, MD joins DeepSight as Vice President of Strategic Partnerships

SANTA CLARA, Calif., Oct. 1, 2025 /PRNewswire/ — DeepSight Technology, a leader in advanced interventional ultrasound solutions, is proud to announce the appointment of Bradford Wood, MD, formerly of the National Institutes of Health (NIH), as Vice President of Strategic Partnerships. Dr….

Dr. Sean Raj, MD, MBA, Named Chief Medical Officer of SimonMed Imaging, Expanding Role Alongside Chief Innovation Officer

SCOTTSDALE, Ariz., Sept 14, 2025 – SimonMed Imaging (“SimonMed”), one of the nation’s leading outpatient medical imaging providers and radiology practice, is proud to announce the appointment of Dr. Sean Raj, MD, MBA, to Chief Medical Officer, in addition to his ongoing role as Chief Innovation Officer. A nationally recognized […]

Tempus Receives U.S. FDA Special 510(k) Clearance for Updated Tempus Pixel Device

CHICAGO–(BUSINESS WIRE)–Tempus AI, Inc. (NASDAQ: TEM), a technology company leading the adoption of AI to advance precision medicine, today announced it has received 510(k) clearance from the U.S. Food and Drug Administration (FDA) for its updated Tempus Pixel, an AI-powered cardiac imaging platform. This update allows the generation of T1 […]

Realize Medical and Canon USA Partner to Redefine Procedural Planning Through Spatial Computing with VR and Imaging Technology

Collaboration aims to create the lab of the future, enabling safer, faster, and more precise interventions Key Benefits of Partnership  Integration of VR and imaging: Combines Realize Medical’s VR platform with Canon’s imaging solutions for an immersive and streamlined procedural planning experience. Enhanced clinical decision-making support: Enables safer, faster, and more precise interventions through advanced visualization. Future-ready technology: Builds the foundation for the connected, intelligent interventional lab of the future. Clinical focus areas: Initial applications in pediatric cardiology and adult structural heart disease, with broader expansion planned.  OTTAWA, Ontario, Sept. 10, 2025 (GLOBE NEWSWIRE) — Realize Medical and Canon USA, Inc. today announced a strategic partnership to combine Realize Medical’s cutting-edge VR platform with Canon’s advanced imaging solutions, setting a new standard for procedural planning in interventional medicine. This collaboration combines the power of spatial computing with world-class medical imaging to accelerate safer, faster, and more precise interventions — a critical step toward creating the lab of the future.  “Canon shares our vision for a more connected, intelligent procedural suite,” said Justin Sutherland, Ph.D., Chief Executive Officer of Realize Medical. “This partnership not only enables broader access to Elucis but also accelerates our joint mission to transform clinical decision-making through spatial computing.”  The initial focus of this collaboration will be in pediatric cardiology and adult structural heart disease, with plans to expand into additional interventional specialties in the future.  “The lab of the future will give physicians the ability to plan interventions in a fully immersive mixed reality environment – improving clarity, confidence, and care,” said Jaimin Chung, Managing Director, IXR/VL BU, Canon USA. “Guided by our Made for Life philosophy, Canon Medical’s collaboration with Realize Medical brings this innovation to pediatric intervention today with new applications for adult care already on the horizon.” Realize Medical and Canon USA will showcase their integrated technologies at the Transcatheter Cardiovascular Therapeutics Annual Meeting from October 25–28, 2025, in San Francisco, CA. Representatives are invited to visit Realize Medical in the Canon Medical Booth #1657 for hands-on demonstrations with Elucis.   Media Contact at Realize Medical  Melissa Kois Marketing Lead melissa@realizemed.com | 647-962-9057 www.realizemed.com   Media Contact at Canon USA  Oliva DuarteDirector, Corporate Communicationsoduarte@us.medical.canon | 831-877-0590https://us.medical.canon/

Two New Publications from the Independent THERMAC Trial Featuring IceCure’s ProSense® in Breast Cancer Finds 95% of Patients Satisfied with Thermal Ablation; ProSense® Cryoablation Achieves Highest Complete Ablation Rate

Article published in European Journal of Surgical Oncology focused on cosmetic outcomes and patient satisfaction reports 95% of patients were very satisfied or satisfied with thermal ablation Article published in Radiology demonstrated that cryoablation with ProSense® achieved the highest…

OneMedNet initiates new Subscription Revenue model in partnership with Circle CVI

MINNEAPOLIS, Aug. 18, 2025 (GLOBE NEWSWIRE) — OneMedNet Corporation (Nasdaq:ONMD) (“OneMedNet” or the “Company”), a leader in AI-powered Real-World Data (RWD) announced a long-term strategic partnership with Circle Cardiovascular Imaging Inc. (Circle CVI), a global leader in advanced cardiovascular imaging solutions. The collaboration reflects Circle CVI’s commitment to leveraging trusted, high-quality data to drive innovation in cardiac diagnostics, treatment planning, and AI model development with data being delivered in the next 30 days. Circle CVI selected OneMedNet’s iRWD™ platform to access diverse and regulatory-grade imaging, ECG, and other cardiovascular datasets that align with the stringent requirements of healthcare AI innovation. By partnering with OneMedNet, Circle CVI gains secure, de-identified access to a growing network of real-world cardiovascular imaging data from over 1,750 provider sites — spanning over 131 million exams critical to developing, validating, and improving advanced cardiovascular solutions. “Our initial experience with OneMedNet was exceptional — the quality, depth, and regulatory readiness of the data exceeded our expectations. It quickly became clear that this wasn’t just a one-time transaction, but the beginning of a long-term collaboration. That’s why we made the decision to partner with OneMedNet and move forward with a subscription — so we can continually access the high-quality, Real-World imaging data we trust to power our innovation,” said Erkan Akyuz, CEO of Circle CVI. This strategic collaboration enables Circle CVI to expand its research and development capabilities while ensuring alignment with evolving regulatory and clinical evidence standards. It also exemplifies a growing industry shift toward real-world evidence as a foundation for medical innovation. “We’re thrilled to enter into this long-term, collaborative relationship with Circle CVI,” said Aaron Green, President and CEO of OneMedNet. “This partnership is a testament to the quality of our Real-World Data — trusted by leading healthcare companies to accelerate innovation, by meeting the precise customer requirements for longitudinal clinical data with the ultimate goal of improving patient outcomes.” About OneMedNet Corporation OneMedNet is revolutionizing how the world unlocks Real-World Data (RWD), harnessing the untapped potential of over 1,750 healthcare sites through its iRWD™ platform. This isn’t just data — it’s the lifeblood of innovation, from de-identified medical imaging to electronic health records, fueling breakthroughs for drugmakers, medical device pioneers, and AI visionaries. With a network spanning rare diseases, oncology, cardiology, and beyond, OneMedNet delivers precision insights that redefine patient care and power the next wave of healthcare disruption. Beyond healthcare OneMedNet’s proprietary AI anonymizes data for industries like finance, retail, and telecom, unlocking endless possibilities — rigorously testing production system upgrades, de-risking complex projects, and securely sharing sensitive data by stripping out personal information. Learn more at www.onemednet.com. About Circle Cardiovascular Imaging Circle Cardiovascular Imaging (Circle CVI) is a Canadian-based company that was founded in 2007, established with the aim of developing innovative software solutions to enhance cardiovascular and cerebrovascular imaging analysis and improve patient care. Circle CVI’s imaging platform provides best-in-class image reading and reporting for quantitative and qualitative assessment of cardiac MR, cardiac CT, vascular CT, and neuro CT. At the heart of Circle CVI’s operations is a relentless commitment to providing improved solutions for healthcare providers, ultimately driving better healthcare outcomes. This commitment fuels the company’s creativity, guides its decision making, and underpins its passion for innovation. Annually, millions of medical imaging exams — in over 1700 hospitals and in more than 90 countries — are estimated to be interpreted using cvi42. For additional information, please visit www.circlecvi.com or contact: marketing@circlecvi.com Cautionary Note Regarding Forward-Looking Statements This press release contains forward-looking statements. All statements other than statements of historical facts contained in this press release are forward-looking statements. We base these forward-looking statements on our current expectations and projections about future events, which we derive from the information presently available to us. Such forward-looking statements relate to future events or our future performance, including: our financial performance and projections; our growth in revenue and earnings; and our business prospects and opportunities. You can identify forward-looking statements by those that are not historical in nature, particularly those that use terminology such as “may,” “should,” “expects,” “anticipates,” “contemplates,” “estimates,” “believes,” “plans,” “projected,” “predicts,” “potential,” or “hopes” or the negative of these or similar terms. In evaluating these forward-looking statements, you should consider various factors, including: our ability to change the direction of OneMedNet; our ability to keep pace with new technology and changing market needs; the competitive environment of our business; risks inherent with investing in Bitcoin, including Bitcoin’s volatility; and our ability to implement our Bitcoin treasury strategy and its effects on our business. These and other factors may cause our actual results to differ materially from any forward-looking statement. Forward-looking statements are only predictions. The forward-looking events discussed in this press release and other statements made from time to time by us or our representatives, may not occur, and actual events and results may differ materially and are subject to risks, uncertainties, and assumptions about us. We undertake no obligation to update publicly any forward-looking statements for any reason after the date of this press release to conform these statements to actual results or to changes in our expectations. OneMedNet Contacts: Michael Wong, VP Marketing Email: michael.wong@onemednet.com SOURCE: ONEMEDNET CORPORATION